News · 26 weeks42+50%
2025-10-262026-04-19
Mix2390d
- Insider12(52%)
- SEC Filings5(22%)
- Other4(17%)
- Earnings2(9%)
Latest news
25 items- INSIDERSEC Form 4 filed by Hair Mark4 - TREACE MEDICAL CONCEPTS, INC. (0001630627) (Issuer)
- SECTreace Medical Concepts Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Leadership Update8-K - TREACE MEDICAL CONCEPTS, INC. (0001630627) (Filer)
- PRTreace Announces First Surgical Cases with the SuperBite™ Compression Screw SystemPONTE VEDRA, Fla., April 07, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. ("Treace" or the "Company") (NASDAQ:TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities, today announced the successful completion of the first cases utilizing its SuperBite™ Compression Screw System. SuperBite™ screws are engineered to deliver advanced compression through a variable thread pitch and optimized headless design, with its self-drilling and countersinking features enabling rapid screw insertion. The screw implants also incorporate a beveled head design with smoothed edges, making them ideal for both minimally inva
- SECSEC Form DEF 14A filed by Treace Medical Concepts Inc.DEF 14A - TREACE MEDICAL CONCEPTS, INC. (0001630627) (Filer)
- SECSEC Form DEFA14A filed by Treace Medical Concepts Inc.DEFA14A - TREACE MEDICAL CONCEPTS, INC. (0001630627) (Filer)
- INSIDERSEC Form 4 filed by Hair Mark4 - TREACE MEDICAL CONCEPTS, INC. (0001630627) (Issuer)
- INSIDERChief Executive Officer Treace John T. covered exercise/tax liability with 7,083 shares, decreasing direct ownership by 0.10% to 7,004,550 units (SEC Form 4)4 - TREACE MEDICAL CONCEPTS, INC. (0001630627) (Issuer)
- INSIDERChief Financial Officer Hair Mark covered exercise/tax liability with 4,659 shares, decreasing direct ownership by 0.54% to 863,549 units (SEC Form 4)4 - TREACE MEDICAL CONCEPTS, INC. (0001630627) (Issuer)
- INSIDERChief Legl & Comp Off, CorpSec Elder Scot Michael covered exercise/tax liability with 1,850 shares, decreasing direct ownership by 0.23% to 794,936 units (SEC Form 4)4 - TREACE MEDICAL CONCEPTS, INC. (0001630627) (Issuer)
- INSIDERChief Innovation Officer Scanlan Sean F. covered exercise/tax liability with 1,797 shares, decreasing direct ownership by 0.25% to 704,677 units (SEC Form 4)4 - TREACE MEDICAL CONCEPTS, INC. (0001630627) (Issuer)
- SECSEC Form 10-K filed by Treace Medical Concepts Inc.10-K - TREACE MEDICAL CONCEPTS, INC. (0001630627) (Filer)
- SECTreace Medical Concepts Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - TREACE MEDICAL CONCEPTS, INC. (0001630627) (Filer)
- PRTreace Medical Concepts Reports Fourth Quarter and Full-Year 2025 Financial ResultsPONTE VEDRA, Fla., Feb. 27, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. ("Treace" or the "Company") (NASDAQ:TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities, today reported financial results for the fourth quarter and full-year ended December 31, 2025. Recent Highlights Generated revenue of $62.5 million in fourth quarter 2025 and revenue of $212.7 million for the full-year 2025, an increase of 2% compared to the prior year.Reported fourth quarter 2025 net loss of $(9.4) million and adjusted EBITDA of $6.2 million in the fourth quarter 2025. Reported full-year 2025 net loss of $(59.0) million c
- PRTreace Highlights New Product Innovations and Updated Positive Clinical Study Data at the 2026 ACFAS Annual Scientific ConferencePONTE VEDRA, Fla., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. ("Treace" or the "Company") (NASDAQ:TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities, today announced it will highlight new product innovations and present new interim data for the ALIGN3D™, MTA3D™, and SpeedMTP® clinical studies at the American College of Foot and Ankle Surgeons ("ACFAS") Annual Scientific Conference in Las Vegas, Nevada from February 24-26, 2026. "We are proud to showcase our latest clinical data and innovations at ACFAS, including our next-generation Lapiplasty® instrumentation and fixation technology pla
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Treace Medical Concepts Inc.SCHEDULE 13G/A - TREACE MEDICAL CONCEPTS, INC. (0001630627) (Subject)
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Treace Medical Concepts Inc.SCHEDULE 13G/A - TREACE MEDICAL CONCEPTS, INC. (0001630627) (Subject)
- PRTreace Updates Date of Fourth Quarter and Full-Year 2025 Financial Results Release to February 27, 2026PONTE VEDRA, Fla., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. ("Treace" or the "Company") (NASDAQ:TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities, today announced that it will release financial results for the fourth quarter and full year of 2025 before the open of trading on Friday, February 27, 2026. Company management will host a conference call to discuss financial results beginning at 8:00 am ET. Investors interested in listening to the conference call may do so by registering. Once registered, participants will receive dial-in numbers and a unique pin to join the call and ask qu
- INSIDERChief Innovation Officer Scanlan Sean F. exercised 16,875 shares at a strike of $1.05, increasing direct ownership by 2% to 706,474 units (SEC Form 4)4 - TREACE MEDICAL CONCEPTS, INC. (0001630627) (Issuer)
- INSIDERChief Innovation Officer Scanlan Sean F. exercised 53,500 shares at a strike of $0.72 and was granted 262,500 shares, increasing direct ownership by 85% to 689,599 units (SEC Form 4)4 - TREACE MEDICAL CONCEPTS, INC. (0001630627) (Issuer)
- INSIDERChief Executive Officer Treace John T. covered exercise/tax liability with 14,254 shares and was granted 250,000 shares, increasing direct ownership by 3% to 7,011,633 units (SEC Form 4)4 - TREACE MEDICAL CONCEPTS, INC. (0001630627) (Issuer)
- INSIDERChief Commercial Officer Guglielmino Gaetano was granted 150,000 shares, increasing direct ownership by 44% to 490,901 units (SEC Form 4)4 - TREACE MEDICAL CONCEPTS, INC. (0001630627) (Issuer)
- INSIDERChief Legl & Comp Off, CorpSec Elder Scot Michael covered exercise/tax liability with 9,451 shares and was granted 262,500 shares, increasing direct ownership by 47% to 796,786 units (SEC Form 4)4 - TREACE MEDICAL CONCEPTS, INC. (0001630627) (Issuer)
- INSIDERChief Financial Officer Hair Mark covered exercise/tax liability with 17,037 shares and was granted 375,000 shares, increasing direct ownership by 70% to 868,208 units (SEC Form 4)4 - TREACE MEDICAL CONCEPTS, INC. (0001630627) (Issuer)
- INSIDERChief Legl & Comp Off, CorpSec Elder Scot Michael covered exercise/tax liability with 4,544 shares, decreasing direct ownership by 0.83% to 543,737 units (SEC Form 4)4 - TREACE MEDICAL CONCEPTS, INC. (0001630627) (Issuer)
- INSIDERChief Executive Officer Treace John T. covered exercise/tax liability with 13,219 shares, decreasing direct ownership by 0.19% to 6,775,887 units (SEC Form 4)4 - TREACE MEDICAL CONCEPTS, INC. (0001630627) (Issuer)